PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS2 holders
Total Value
$11.63M
Total Shares
10.97M
Net Share Change
+10.17M
Activity
2 buying
Investor
Value
Shares
Weight
Change
Miller Value Partners
$10.07M9.50M sharesNEW
